Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Neurocrine Biosciences Research and Development Expenses 2010-2025 | NBIX

Neurocrine Biosciences annual/quarterly research and development expenses history and growth rate from 2010 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • Neurocrine Biosciences research and development expenses for the quarter ending March 31, 2025 were $0.263B, a 65.12% increase year-over-year.
  • Neurocrine Biosciences research and development expenses for the twelve months ending March 31, 2025 were $0.835B, a 42.74% increase year-over-year.
  • Neurocrine Biosciences annual research and development expenses for 2024 were $0.731B, a 29.4% increase from 2023.
  • Neurocrine Biosciences annual research and development expenses for 2023 were $0.565B, a 21.82% increase from 2022.
  • Neurocrine Biosciences annual research and development expenses for 2022 were $0.464B, a 41.36% increase from 2021.
  
Neurocrine Biosciences Annual Research and Development Expenses
(Millions of US $)
2024 $731
2023 $565
2022 $464
2021 $328
2020 $275
2019 $200
2018 $156
2017 $92
2016 $94
2015 $81
2014 $46
2013 $39
2012 $37
2011 $31
2010 $31
2009 $34
Neurocrine Biosciences Quarterly Research and Development Expenses
(Millions of US $)
2025-03-31 $263
2024-12-31 $186
2024-09-30 $195
2024-06-30 $191
2024-03-31 $159
2023-12-31 $138
2023-09-30 $142
2023-06-30 $146
2023-03-31 $140
2022-12-31 $118
2022-09-30 $108
2022-06-30 $136
2022-03-31 $102
2021-12-31 $87
2021-09-30 $93
2021-06-30 $75
2021-03-31 $73
2020-12-31 $67
2020-09-30 $69
2020-06-30 $81
2020-03-31 $58
2019-12-31 $55
2019-09-30 $45
2019-06-30 $62
2019-03-31 $38
2018-12-31 $34
2018-09-30 $35
2018-06-30 $37
2018-03-31 $49
2017-12-31 $-4
2017-09-30 $22
2017-06-30 $22
2017-03-31 $52
2016-12-31 $23
2016-09-30 $21
2016-06-30 $27
2016-03-31 $24
2015-12-31 $22
2015-09-30 $24
2015-06-30 $19
2015-03-31 $17
2014-12-31 $15
2014-09-30 $12
2014-06-30 $10
2014-03-31 $9
2013-12-31 $9
2013-09-30 $9
2013-06-30 $11
2013-03-31 $10
2012-12-31 $9
2012-09-30 $10
2012-06-30 $9
2012-03-31 $9
2011-12-31 $8
2011-09-30 $7
2011-06-30 $8
2011-03-31 $7
2010-12-31 $8
2010-09-30 $8
2010-06-30 $7
2010-03-31 $8
2009-12-31 $5
2009-09-30 $7
2009-06-30 $11
2009-03-31 $11
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $13.047B $2.355B
Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $77.504B 29.07
Zoetis (ZTS) United States $65.610B 24.48
Daiichi Sankyo, - (DSNKY) Japan $46.052B 23.60
Takeda Pharmaceutical (TAK) Japan $45.947B 9.14
BeOne Medicines - (ONC) Cayman Islands $31.996B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.212B 0.00
Summit Therapeutics (SMMT) United States $19.562B 0.00
Merck (MKKGY) Germany $16.608B 12.17
Shionogi (SGIOY) Japan $14.377B 14.40
United Therapeutics (UTHR) United States $13.222B 11.70
Orion OYJ (ORINY) Finland $10.973B 26.45
IPSEN (IPSEY) France $10.477B 0.00
Corcept Therapeutics (CORT) United States $7.436B 60.45
Madrigal Pharmaceuticals (MDGL) United States $7.348B 0.00
Stevanato Group S.p.A (STVN) Italy $7.320B 44.76
Grifols, S.A (GRFS) Spain $6.876B 0.00
Ionis Pharmaceuticals (IONS) United States $6.613B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.383B 0.00
Procaps Group, S.A (PROCF) Luxembourg $3.202B 0.00
Hypermarcas (HYPMY) Brazil $3.004B 19.76
Crinetics Pharmaceuticals (CRNX) United States $2.898B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.563B 8.98
NewAmsterdam Pharma (NAMS) Netherlands $2.533B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.479B 13.41
Centessa Pharmaceuticals (CNTA) United Kingdom $2.145B 0.00
Ocular Therapeutix (OCUL) United States $1.834B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.783B 0.00
ARS Pharmaceuticals (SPRY) United States $1.753B 0.00
Endo (NDOI) United States $1.656B 0.00
Harrow (HROW) United States $1.360B 0.00
Guardian Pharmacy Services (GRDN) United States $1.322B 0.00
Evotec AG (EVO) Germany $1.310B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.165B 23.30
Enliven Therapeutics (ELVN) United States $1.073B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.062B 0.00
Ardelyx (ARDX) United States $1.058B 0.00
Dyne Therapeutics (DYN) United States $1.042B 0.00
Akebia Therapeutics (AKBA) United States $1.009B 0.00
Collegium Pharmaceutical (COLL) United States $0.993B 5.36
Verve Therapeutics (VERV) United States $0.974B 0.00
ProKidney (PROK) United States $0.942B 0.00
Cronos Group (CRON) Canada $0.806B 0.00
Xeris Biopharma Holdings (XERS) United States $0.804B 0.00
KalVista Pharmaceuticals (KALV) United States $0.777B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.732B 0.00
Xencor (XNCR) United States $0.648B 0.00
Zevra Therapeutics (ZVRA) United States $0.641B 0.00
Relay Therapeutics (RLAY) United States $0.622B 0.00
Organogenesis (ORGO) United States $0.578B 0.00
Elite Pharmaceuticals (ELTP) United States $0.569B 0.00
Theravance Biopharma (TBPH) United States $0.568B 0.00
USANA Health Sciences (USNA) United States $0.564B 12.26
Bioventus (BVS) United States $0.518B 13.12
Oruka Therapeutics (ORKA) United States $0.516B 0.00
Siga Technologies (SIGA) United States $0.489B 10.22
Tourmaline Bio (TRML) United States $0.468B 0.00
Aquestive Therapeutics (AQST) United States $0.420B 0.00
Savara (SVRA) United States $0.396B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.350B 9.46
Tonix Pharmaceuticals Holding (TNXP) United States $0.332B 0.00
Altimmune (ALT) United States $0.328B 0.00
Aldeyra Therapeutics (ALDX) United States $0.323B 0.00
Nektar Therapeutics (NKTR) United States $0.308B 0.00
AleAnna (ANNA) United States $0.300B 0.00
Heron Therapeutics (HRTX) United States $0.293B 0.00
Nature's Sunshine Products (NATR) United States $0.273B 25.08
OmniAb (OABI) United States $0.242B 0.00
Nanobiotix S.A (NBTX) France $0.241B 0.00
Esperion Therapeutics (ESPR) United States $0.228B 0.00
MediWound (MDWD) Israel $0.217B 0.00
Larimar Therapeutics (LRMR) United States $0.209B 0.00
4D Molecular Therapeutics (FDMT) United States $0.196B 0.00
China SXT Pharmaceuticals (SXTC) China $0.188B 0.00
Aclaris Therapeutics (ACRS) United States $0.178B 0.00
Galectin Therapeutics (GALT) United States $0.173B 0.00
Journey Medical (DERM) United States $0.168B 0.00
Profound Medical (PROF) Canada $0.167B 0.00
Liminatus Pharma (LIMN) United States $0.145B 0.00
Lyell Immunopharma (LYEL) United States $0.141B 0.00
Inhibikase Therapeutics (IKT) United States $0.140B 0.00
Avita Medical (RCEL) United States $0.138B 0.00
Protara Therapeutics (TARA) United States $0.132B 0.00
Lexeo Therapeutics (LXEO) United States $0.131B 0.00
Korro Bio (KRRO) United States $0.125B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.124B 0.00
Cassava Sciences (SAVA) United States $0.111B 0.00
Champions Oncology (CSBR) United States $0.111B 18.25
Innate Pharma SA (IPHYF) France $0.110B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.105B 0.00
Cardiol Therapeutics (CRDL) Canada $0.101B 0.00
VAXART, INC (VXRT) United States $0.097B 0.00
Achieve Life Sciences (ACHV) Canada $0.092B 0.00
Vivani Medical (VANI) United States $0.092B 0.00
Nutriband (NTRB) United States $0.092B 0.00
Fractyl Health (GUTS) United States $0.088B 0.00
Wellgistics Health (WGRX) United States $0.085B 0.00
Arch Biopartners (ACHFF) Canada $0.084B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Metagenomi (MGX) United States $0.081B 0.00
Context Therapeutics (CNTX) United States $0.078B 0.00
Dominari Holdings (DOMH) United States $0.076B 0.00
Surrozen (SRZN) United States $0.074B 0.00
Rafael Holdings (RFL) United States $0.074B 0.00
Avalo Therapeutics (AVTX) United States $0.073B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.071B 0.00
Pyxis Oncology (PYXS) United States $0.070B 0.00
PMV Pharmaceuticals (PMVP) United States $0.070B 0.00
Assertio Holdings (ASRT) United States $0.067B 0.00
Telomir Pharmaceuticals (TELO) United States $0.066B 0.00
Inotiv (NOTV) United States $0.059B 0.00
Jupiter Neurosciences (JUNS) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Unicycive Therapeutics (UNCY) United States $0.057B 0.00
Klotho Neurosciences (KLTO) United States $0.055B 0.00
ElectroCore (ECOR) United States $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 38.89
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Prelude Therapeutics (PRLD) United States $0.048B 0.00
Gain Therapeutics (GANX) United States $0.048B 0.00
Acrivon Therapeutics (ACRV) United States $0.044B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
PolyPid (PYPD) Israel $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.035B 0.00
Karyopharm Therapeutics (KPTI) United States $0.035B 0.00
Vivos Therapeutics (VVOS) United States $0.032B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Scienture Holdings (SCNX) United States $0.028B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Incannex Healthcare (IXHL) Australia $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Plus Therapeutics (PSTV) United States $0.020B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.018B 0.00
DURECT (DRRX) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
CASI Pharmaceuticals (CASI) China $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
BioVie (BIVI) United States $0.014B 0.00
Minerva Neurosciences (NERV) United States $0.014B 2.37
TherapeuticsMD (TXMD) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Ainos (AIMD) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.005B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SHINECO (SISI) China $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.12
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00